youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,67 US$
arrow_downward
-8,87%(-0,26) 1D
2,70 US$
arrow_upward
+1,12% (+0,030)bedtimeAfter hours
Closed: 30 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,89 US$
High
2,92 US$
Low
2,60 US$
Mkt. cap
410,06 მლნ.
Avg. vol.
2,97 მლნ.
Volume
2,91 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,89 US$
High
2,92 US$
Low
2,60 US$
Mkt. cap
410,06 მლნ.
Avg. vol.
2,97 მლნ.
Volume
2,91 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
Yahoo! Finance Canada
·
9 წუთის წინ
MARA Holdings, Inc. (MARA) Seasonal Returns Chart - Yahoo Finance
TradingView
·
1 საათის წინ
NASDAQ Pre-Market Range Sweep Indicator October 26-30 for OANDA:NAS100USD by josseliani
Foreign Policy Journal
·
1 საათის წინ
Netflix (NASDAQ: NFLX) Stock Price Trades 26% Below Fair Value Estimate As Cash Flow Debate Intensifies
CNBC
·
10 საათის წინ
Anthropic's path to the Nasdaq just got a lot bumpier
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc